Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Case Report

Published on 09 Jan 2023

Toxic epidermal necrosis associated with afatinib: A case report and literature review

in Pharmacology of Anti-Cancer Drugs

Wei Yang
Yansong Lu
Ze Wu
Jun Niu

Frontiers in Oncology

doi 10.3389/fonc.2022.1010052

2,003 views
5 citations

Original Research

Published on 06 Jan 2023

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27

in Pharmacology of Anti-Cancer Drugs

Pengfei Qiao
Zhentao Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.1084884

2,306 views
11 citations

Review

Published on 05 Jan 2023

New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy

in Pharmacology of Anti-Cancer Drugs

Abdulrahman Theyab
Khalaf F. Alsharif
Khalid J. Alzahrani
Atif Abdulwahab A. Oyouni
Yousef MohammedRabaa Hawsawi
Mohammad Algahtani
Saad Alghamdi
Amal F. Alshammary

Frontiers in Oncology

doi 10.3389/fonc.2022.1026377

6,946 views
13 citations

Review

Published on 04 Jan 2023

Advances in research on the relationship between thymoquinone and pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Zhanxue Zhao
Linxun Liu
Shuai Li
Xiaofan Hou
Jinyu Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1092020

9,257 views
13 citations

Review

Published on 04 Jan 2023

The function of natural compounds in important anticancer mechanisms

in Pharmacology of Anti-Cancer Drugs

Yang Nan
Hongchan Su
Bo Zhou
Shumin Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1049888

10,806 views
46 citations

Editorial

Published on 22 Dec 2022

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing

in Pharmacology of Anti-Cancer Drugs

Rajkumar Singh Kalra
Sandeep Singh
Anjana Munshi
Jitender Bariwal

Frontiers in Oncology

doi 10.3389/fonc.2022.1106610

1,340 views

Review

Published on 22 Dec 2022

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders

in Pharmacology of Anti-Cancer Drugs

Elsa Maitre
Jerome Paillassa
Xavier Troussard

Frontiers in Oncology

doi 10.3389/fonc.2022.1068981

5,951 views
11 citations

Mini Review

Published on 20 Dec 2022

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies

in Pharmacology of Anti-Cancer Drugs

Shenhe Jin
Ye Zhang
Fengping Zhou
Xiaochang Chen
Jianpeng Sheng
Jin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1091782

7,963 views
16 citations

Clinical Trial

Published on 20 Dec 2022

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer

in Pharmacology of Anti-Cancer Drugs

Yinjuan Li
Lu Qi
Yu Wang
Yan Li
Chunpu Lei
Yingjuan Zhang
Xiaoqiang Cheng
Ju Liu
HaiHong Bai
Xia Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1070001

4,422 views
3 citations

Original Research

Published on 16 Dec 2022

siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro

in Pharmacology of Anti-Cancer Drugs

Xiaoli Cui
Zhou Yao
Tianyu Zhao
Jiahui Guo
Jipeng Ding
Siwei Zhang
Zuowen Liang
Zhengren Wei
Alexis Zoa
Yuantong Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.1069033

2,983 views
5 citations

Case Report

Published on 15 Dec 2022

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Emaan Haque
Ibrahim N. Muhsen
Abdullah Esmail
Godsfavour Umoru
Charisma Mylavarapu
Veronica B. Ajewole
Maen Abdelrahim

Frontiers in Oncology

doi 10.3389/fonc.2022.992455

2,380 views
2 citations

Original Research

Published on 15 Dec 2022

MALDI-TOF-MS for rapid screening analysis of M-protein in serum

in Pharmacology of Anti-Cancer Drugs

Jie Li
Anping Xu
Weijie Xie
Bowen Li
Cunliang Yan
Yong Xia
Chao Liang
Ling Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.1073479

4,957 views
6 citations

Brief Research Report

Published on 12 Dec 2022

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine

in Pharmacology of Anti-Cancer Drugs

Dominique Bollino
J. Preston Claiborne
Kanwal Hameed
Xinrong Ma
Kayla M. Tighe
Brandon Carter-Cooper
Rena G. Lapidus
Erin T. Strovel
Ashkan Emadi

Frontiers in Oncology

doi 10.3389/fonc.2022.1035537

3,347 views
3 citations

Original Research

Published on 09 Dec 2022

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets

in Pharmacology of Anti-Cancer Drugs

Na Xu
Baohong Li
Yong Liu
Cui Yang
Siqi Tang
William C. Cho
Zunnan Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1017041

7,382 views
11 citations

Original Research

Published on 09 Dec 2022

Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development

in Pharmacology of Anti-Cancer Drugs

Zhili Wen
Ke He
Meixiao Zhan
Yong Li
Fei Liu
Xu He
Yanli Wei
Wei Zhao
Yu Zhang
Yaqiang Xue

Frontiers in Oncology

doi 10.3389/fonc.2022.904633

3,875 views
1 citation

Review

Published on 08 Dec 2022

Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices

in Pharmacology of Anti-Cancer Drugs

Pattanaik Smita
Patil Amol Narayan
Kumaravel J
Prakash Gaurav

Frontiers in Oncology

doi 10.3389/fonc.2022.1015200

10,161 views
24 citations